Medicare Enrolled
Dr. John Banzer, M.D.
Internal Medicine · Silverdale, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Banzer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Banzer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Banzer
Dr. John Banzer is an internal medicine specialist in Silverdale, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Banzer performed 4,405 Medicare services across 2,250 unique beneficiaries.
Between the years covered by Open Payments, Dr. Banzer received a total of $9,840 from 43 pharmaceutical and/or device companies across 598 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Banzer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in WA
$9,840 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,405
Medicare services
Top 2% in WA for internal medicine
2,250
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~220 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,716 | $90 | $366 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
738 | $8 | $33 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
541 | $4 | $14 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
220 | $150 | $591 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
149 | $57 | $219 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
118 | $11 | $43 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
94 | $37 | $159 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
80 | $16 | $70 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
80 | $93 | $288 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
73 | $20 | $86 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
71 | $9 | $41 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
70 | $19 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
65 | $122 | $476 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
59 | $9 | $41 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
58 | $18 | $68 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
49 | $63 | $233 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
40 | $136 | $533 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
36 | $35 | $151 |
| Implantable defibrillator system check A check of the implanted defibrillator device to ensure it is functioning correctly. This evaluation covers single, dual, or multiple lead systems. |
29 | $47 | $210 |
| Exercise or drug-induced heart stress test with ECG A test that monitors the heart's electrical activity while the patient exercises or receives medication to increase heart rate. |
27 | $21 | $105 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
27 | $9 | $40 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
26 | $12 | $62 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
24 | $76 | $330 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
15 | $25 | $166 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.7% high complexity
6.6% medium
80.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,840
Total received (2018-2024)
Avg $1,406/year across 7 years
Top 7% in WA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
598
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,840 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,998
2023
$1,705
2022
$1,899
2021
$1,104
2020
$1,077
2019
$1,106
2018
$951
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$296
E.R. Squibb & Sons, L.L.C.
$284
Bayer Healthcare Pharmaceuticals Inc.
$242
Amgen Inc.
$152
AstraZeneca Pharmaceuticals LP
$147
Novo Nordisk Inc
$139
Novartis Pharmaceuticals Corporation
$136
Kiniksa Pharmaceuticals International, plc
$109
Merck Sharp & Dohme LLC
$94
PFIZER INC.
$89
Lexicon Pharmaceuticals, Inc.
$71
Janssen Pharmaceuticals, Inc
$47
Boston Scientific Corporation
$35
Alnylam Pharmaceuticals Inc.
$33
Lilly USA, LLC
$24
Azurity Pharmaceuticals, Inc.
$22
Chiesi USA, Inc.
$22
iRhythm Technologies, Inc.
$19
Alexion Pharmaceuticals, Inc.
$19
Baxter Healthcare
$17
Top 3 companies account for 41.1% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,497
Amgen Inc.
$1,372
AstraZeneca Pharmaceuticals LP
$906
Novartis Pharmaceuticals Corporation
$828
E.R. Squibb & Sons, L.L.C.
$740
Novo Nordisk Inc
$723
Bayer Healthcare Pharmaceuticals Inc.
$464
PFIZER INC.
$417
Amarin Pharma Inc.
$293
Boston Scientific Corporation
$261
Janssen Pharmaceuticals, Inc
$253
Merck Sharp & Dohme LLC
$238
Xeris Pharmaceuticals, Inc.
$168
Otsuka America Pharmaceutical, Inc.
$162
BOSTON SCIENTIFIC CORPORATION
$139
Bayer HealthCare Pharmaceuticals Inc.
$134
Lexicon Pharmaceuticals, Inc.
$115
Lundbeck LLC
$113
Kiniksa Pharmaceuticals International, plc
$109
Esperion Therapeutics, Inc.
$98
Kiniksa Pharmaceuticals, Ltd.
$77
Lilly USA, LLC
$71
ATRICURE, INC.
$66
SANOFI-AVENTIS U.S. LLC
$65
Insulet Corporation
$53
Alnylam Pharmaceuticals Inc.
$52
Medtronic Vascular, Inc.
$48
Chiesi USA, Inc.
$46
Kyowa Kirin, Inc.
$45
Kowa Pharmaceuticals America, Inc.
$38
iRhythm Technologies, Inc.
$36
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$23
LIFESCAN, INC.
$23
Azurity Pharmaceuticals, Inc.
$22
Impulse Dynamics (USA) Inc.
$21
Alexion Pharmaceuticals, Inc.
$19
LifeScan, Inc.
$18
Neurocrine Biosciences, Inc.
$17
Baxter Healthcare
$17
Regeneron Healthcare Solutions, Inc.
$16
Mitsubishi Tanabe Pharma America, Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$13
Echosens North America, Inc.
$11
Top 3 companies account for 38.4% of all-time payments
Associated products mentioned in payments ›
AMS · ATRICLIP LAA EXCLUSION SYSTEM · Aimovig · Arcalyst · BRILINTA · BodyGuardian · CAMZYOS · CHANTIX · CLEVIPREX · Crysvita · EDARBYCLOR · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FibroScan · GVOKE HYPOPEN · GVOKE PFS · Hillrom - Cardiac Ambulatory Monitor · INGREZZA · Inpefa · JARDIANCE · JYNARQUE · Kerendia · LEQVIO · LOKELMA · LifeVest · Livalo · MOUNJARO · MULTAQ · NEXLETOL · NORTHERA · NOURIANZ · ONETOUCH VERIO FLEX · ONPATTRO · OT Verio Flex Starter Kit · Omnipod · Optimizer · Otezla · Ozempic · PRADAXA · PRALUENT · Prolia · RYBELSUS · Radicava · Repatha · Reveal LINQ · Rybelsus · SAMSCA · SOLIQUA 100/33 · TOUJEO · TRADJENTA · TRULICITY · ULTOMIRIS · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in WA.
Geographic Context
Internal medicine physicians within 10 mi
1,712
Per 100K population
619.0
County median income
$98,546
Nearest hospital
HARRISON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Banzer is a clinical cardiology specialist, with above-average Medicare volume (top 2% in WA), with low-engagement industry engagement in the top 7% of WA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Banzer experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Banzer performed 1,716 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Banzer receive payments from pharmaceutical companies?
Yes. Dr. Banzer received a total of $9,840 from 43 companies across 598 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Banzer's costs compare to other internal medicine physicians in Silverdale?
Dr. Banzer's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Banzer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Silverdale
Browse internal medicine physicians in Silverdale ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in WA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in WA
Which WA internal medicine physicians receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology